The brown adipose cell: A model for understanding the molecular mechanisms of insulin resistance

Acta Physiologica Scandinavica

Volumn 183, Issue 1, 2005, Pages 59-73

  Valverde, A M ^a   Benito, M ^a   Lorenzo, M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Brown adipocytes; Fatty acid synthase; GLUT4; Insulin receptor substrate; Insulin resistance; Rosiglitazone; Transforming growth factor ; Uncoupling protein 1

Indexed keywords

CYTOKINE; FATTY ACID SYNTHASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE B; PROTEIN KINASE C LAMBDA; ROSIGLITAZONE; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN 1;

ANIMAL CELL; ANIMAL TISSUE; BROWN ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL MEMBRANE TRANSPORT; CELL SURVIVAL; ENZYME ACTIVATION; FETUS DEVELOPMENT; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; HUMAN TISSUE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC DISORDER; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; REVIEW; SIGNAL TRANSDUCTION;

ADIPOCYTES; ADIPOSE TISSUE, BROWN; BIOLOGICAL TRANSPORT; CELL DIFFERENTIATION; GLUCOSE; HOMEOSTASIS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; THERMOGENESIS;

EID: 13244258505     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-201X.2004.01384.x     Document Type: Review

References (128)

1. Aguirre, V., Werner, E.D., Giraud, J., Lee, Y.H., Shoelson, S.E. & White, M.F. 2002. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 277, 1531-1537.
2. Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T. & Saltiel, A.R. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270, 27489-27494.
3. Angel, I., Burcelin, R., Prouteau, M., Girard, J. & Langer, S.Z. 1996. Normalization of insulin secretion by a selective alpha 2-adrenoceptor antagonist restores GLUT-4 glucose transporter expression in adipose tissue of type II diabetic rats. Endocrinology 137, 2022-2027.
4. Arner, P. 2003. The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 14, 137-145.
5. Arribas, M., Valverde, A.M. & Benito, M. 2003a. Role of IRS-3 in the insulin signaling of IRS-1-deficient brown adipocytes. J Biol Chem 278, 45189-45199.
6. Arribas, M., Valverde, A.M., Burks, D. et al. 2003b. Essential role of protein kinase C zeta in the impairment of insulin-induced glucose transport in IRS-2-deficient brown adipocytes. FEBS Lett 536, 161-166.
7. Bandyopadhyay, G., Standaert, M.L., Sajan, M.P. et al. 1999. Dependence of insulin-stimulated glucose transporter 4 translocation on 3-phosphoinositide-dependent protein kinase-1 and its target threonine-410 in the activation loop of protein kinase C-zeta. Mol Endocrinol 13, 1766-1772.
8. Bjornholm, M., He, AR., Attersand, A et al. 2002. Absence of functional insulin receptor substrate-3 (IRS-3) gene in humans. Diabetologia 45, 1697-1702.
9. Bruning, J.C., Michael, M.D., Winnay, J.N. et al. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2, 559-569.
10. Camp, H.S., Li, O., Wise, S.C. et al. 2000. Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Diabetes 49, 539-547.
11. Cannon, B. & Nedergaard, J. 2004. Brown adipose tissue: function and physiological significance. Physiol Rev 84, 277-359.
12. Carlson, C.J., Koterski, S., Sciotti, R.J., Poccard, G.B. & Rondinone, C.M. 2003. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. Diabetes 52, 634-641.
13. Cassard-Doulcier, A.M., Gelly, C., Fox, N. et al. 1993. Tissue-specific and beta-adrenergic regulation of the mitochondrial uncoupling protein gene: control by cis-acting elements in the 5′-flanking region. Mol Endocrinol 7, 497-506.
14. Champigny, O. & Ricquier, D. 1996. Evidence from in vitro differentiating cells that adrenoceptor agonists can increase uncoupling protein mRNA level in adipocytes of adult humans: an RT-PCR study. J Lipid Res 37, 1907-1914.
15. Charron, M.J., Katz, E.B. & Olson, A.L. 1999. GLUT4 gene regulation and manipulation. J Biol Chem 274, 3253-3256.
16. Cho, H., Mu, J., Kim, J.K. et al. 2001. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292, 1728-1731.
17. Ciaraldi, T.P., Kong, A.P., Chu, N.V. et al. 2002. Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects. Diabetes 51, 30-36.
18. Clement, K., Ruiz, J., Cassard-Doulcier, A.M. et al. 1996. Additive effect of A → G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta 3-adrenergic receptor gene on weight gain in morbid obesity. IntJ Obes Relat Metab Disord 20, 1062-1066.
19. Conejo, R. & Lorenzo, M. 2001. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts. J Cell Physiol 187, 96-108.
20. De Alvaro, C., Teruel, T., Hernandez, R. & Lorenzo, M. 2004. TNF alpha produces insulin rsistance in skeletal muscle by activation of inhibitor kB in a p38 MAPK-dependent Manner. J Biol Chem 279, 17070-17078.
21. DeFronzo, R.A. 1997. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Neth J Med 50, 191-197.
22. Duchamp, C., Burton, K.A., Geloen, A. & Dauncey, M.J. 1997. Transient upregulation of IGF-I gene expression in brown adipose tissue of cold-exposed rats. Am J Physiol 272, E453-E460.
23. Engelman, J.A., Berg, A.H., Lewis, R.Y., Lisanti, M.P. & Scherer, P.E. 2000. Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes. Mol Endocrinol 14, 1557-1569.
24. Evans, R.M., Barish, G.D. & Wang, Y.X. 2004. PPARs and the complex journey to obesity. Nat Med 10, 355-361.
25. Fasshauer, M., Klein, J., Ueki, K. et al. 2000. Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes. J Biol Chem 275, 25494-25501.
26. Fasshauer, M., Klein, J., Kriauciunas, K.M., Ueki, K., Benito, M. & Kahn, C.R. 2001. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Mol Cell Biol 21, 319-329.
27. Fernandez, A.M., Kim, J.K., Yakar, S. et al. 2001. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev 15, 1926-1934.
28. Ferrari, S., Bannwarth, W., Morley, S.J., Totty, N.F. & Thomas, G. 1992. Activation of p70s6k is associated with phosphorylation of four clustered sites displaying Ser/Thr-Pro motifs. Proc Natl Acad Sci U S A 89, 7282-7286.
29. Ferre, P., Burnol, A.F., Leturque, A. et al. 1986. Glucose utilization in vivoand insulin-sensitivity of rat brown adipose tissuein various physiological and pathological conditions. Biochem J 233, 249-252.
30. Flores-Riveros, J.R., McLenithan, J.C., Ezaki, O. & Lane, M.D. 1993. Insulin down-regulates expression of the insulin-responsive glucose transporter (GLUT4) gene: effects on transcription and mRNA turnover. Proc Natl Acad Sci USA 90, 512-516.
31. Foley, J.E. 1992. Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus. Diabetes Care 15, 773-784.
32. Fujishiro, M., Gotoh, Y., Katagiri, H. et al. 2003. Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes. Mol Endocrinol 17, 487-497.
33. Gao, Z., Hwang, D., Bataille, F. et al. 2002. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 277, 48115-48121.
34. Guerra, C., Roncero, C., Porras, A., Fernandez, M. & Benito, M. 1996. Triiodothyronine induces the transcription of the uncoupling protein gene and stabilizes its mRNA in fetal rat brown adipocyte primary cultures. J Biol Chem 271, 2076-2081.
35. Guerra, C., Navarro, P., Valverde, A.M. et al. 2001. Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance. J Clin Invest 108, 1205-1213.
36. Hajduch, E., Hainault, I., Meunier, C. et al. 1995. Regulation of glucose transporters in cultured rat adipocytes: synergistic effect of insulin and dexamethasone on GLUT4 gene expression through promoter activation. Endocrinology 136, 4782-4789.
37. Hajduch, E., Balendran, A., Batty, I.H. et al. 2001. Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 44, 173-183.
38. Hamann, A., Tafel, J., Busing, B. et al. 1998. Analysis of the uncoupling protein-1 (UCP1) gene in obese and lean subjects: identification of four amino acid variants. Int J Obes Relat Metab Disord 22, 939-941.
39. Hernandez, R., Teruel, T. & Lorenzo, M. 2001. Akt mediates insulin induction of glucose uptake and up-regulation of GLUT4 gene expression in brown adipocytes. FEBS Lett 494, 225-231.
40. Hernandez, R., Teruel, T. & Lorenzo, M. 2003a. Insulin and dexamethasone induce GLUT4 gene expression in foetal brown adipocytes: synergistic effect through CCAAT/enhancer-binding protein alpha. Biochem J 372, 617-624.
41. Hernandez, R., Teruel, T. & Lorenzo, M. 2003b. Rosiglitazone produces insulin sensitisation by increasing expression of the insulin receptor and its tyrosine kinase activity in brown adipocytes. Diabetologia 46, 1618-1628.
42. Hernandez, R., Teruel, T., De Alvaro, C. & Lorenzo, M. 2004. Rosiglitazone ameliorates insulin resistance in brown adipocytes by impairing TNF alpha induction of p38 and p42/p44MAPK. Diabetologia 47, 1615-1624.
43. Higaki, Y., Wojtaszewski, J.F., Hirshman, M.F. et al. 1999. Insulin receptor substrate-2 is not necessary for insulin- and exercise-stimulated glucose transport in skeletal muscle. J Biol Chem 274, 20791-20795.
44. Hirosumi, J., Tuncman, G., Chang, L. et al. 2002. A central role for JNK in obesity and insulin resistance. Nature 420, 333-336.
45. Hotamisligil, G.S. 2003. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27 (Suppl. 3), S53-S55.
46. Hotamisligil, G.S., Shargill, N.S. & Spiegelman, B.M. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91.
47. Hotamisligil, G.S., Murray, D.L., Choy, L.N. & Spiegelman, B.M. 1994. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91, 4854-4858.
48. Hotamisligil, G.S., Arner, P., Caro, J.F., Atkinson, R.L. & Spiegelman, B.M. 1995. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95, 2409-2415.
49. Hotamisligil, G.S., Peraldi, P., Budavari, A., Ellis, R., White, M.F. & Spiegelman, B.M. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271, 665-668.
50. Jiang, G., Dallas-Yang, Q., Li, Z. et al. 2002. Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists. Diabetes 51, 2412-2419.
51. Jiang, G., Dallas-Yang, Q., Biswas, S., Li, Z. & Zhang, B.B. 2004. Rosiglitazone, an agonist of PPARgamma reduces Ser phosphorylation of IRS1 in vitro and in vivo. Biochem J 377, 339-346.
52. Kahn, B.B. & Flier, J.S. 2000. Obesity and insulin resistance. J Clin Invest 106, 473-481.
53. Kayali, A.G., Eichhorn, J., Haruta, T. et al. 1998. Association of the insulin receptor with phospholipase C-gamma (PLC-gamma) in 3T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by insulin. J Biol Chem 273, 13808-13818.
54. Kiec-Wilk, B., Wybranska, I., Malczewska-Malec, M. et al. 2002. Correlation of the -3826A>G polymorphism in the promoter of the uncoupling protein 1 gene with obesity and metabolic disorders in obese families from southern Poland. J Physiol Pharmacol 53, 477-490.
55. Kohn, A.D., Barthel, A., Kovacina, K.S. et al. 1998. Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J Biol Chem 273, 11937-11943.
56. Koistinen, H.A., Chibalin, A.V. & Zierath, J.R. 2003. Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from Type 2 diabetic patients. Diabetologia 46, 1324-1328.
57. Liu, L.S., Spelleken, M., Rohrig, K., Hauner, H. & Eckel, J. 1998. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor. Diabetes 47, 515-522.
58. Lorenzo, M., Valverde, A.M., Teruel, T. & Benito, M. 1993. IGF-I is a mitogen involved in differentiation-related gene expression in fetal rat brown adipocytes. J Cell Biol 123, 1567-1575.
59. Lorenzo, M., Valverde, A.M., Teruel, T., Alvarez, A. & Benito, M. 1996. p21ras induced differentiation-related gene expression in fetal brown adipocyte primary cells and cell lines. Cell Growth Differ 7, 1251-1259.
60. Lorenzo, M., Teruel, T., Hernandez, R., Kayali, A.G. & Webster, N.J. 2002. PLCgamma participates in insulin stimulation of glucose uptake through activation of PKCzeta in brown adipocytes. Exp Cell Res 278, 146-157.
61. Lowell, B.B. 1999. PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function. Cell 99, 239-242.
62. Lyon, C.J., Law, R.E. & Hsueh, W.A. 2003. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144, 2195-2200.
63. Martin, S.S., Haruta, T., Morris, A.J., Klippel, A., Williams, L.T. & Olefsky, J.M. 1996. Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes. J Biol Chem 271, 17605-17608.
64. Meyer, M.M., Levin, K., Grimmsmann, T. et al. 2002. Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycernic subjects at risk for the development of type 2 diabetes. Diabetes 51, 2691-2697.
65. Miki, H., Yamauchi, T., Suzuki, R. et al. 2001. Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation. Mol Cell Biol 21, 2521-2532.
66. Mori, H., Okazawa, H., Iwamoto, K., Maeda, E., Hashiramoto, M. & Kasuga, M. 2001. A polymorphism in the 5′ untranslated region and a Met229 → Leu variant in exon 5 of the human UCP1 gene are associated with susceptibility to type II diabetes mellitus. Diabetologia 44, 373-376.
67. Mur, C., Valverde, A.M., Kahn, C.R. & Benito, M. 2002. Increased insulin sensitivity in IGF-I receptor-deficient brown adipocytes. Diabetes 51, 743-754.
68. Mur, C., Arribas, M., Benito, M. & Valverde, A.M. 2003. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation. Endocrinology 144, 581-593.
69. Nandi, A., Kitamura, Y., Kahn, C.R. & Accili, D. 2004. Mouse models of insulin resistance. Physiol Rev 84, 623-647.
70. Navarro, P., Valverde, A.M., Benito, M. & Lorenzo, M. 1998. Insulin/IGF-I rescues immortalized brown adipocytes from apoptosis down-regulating Bcl-xS expression, in a PI 3-kinase- and map kinase-dependent manner. Exp Cell Res 243, 213-221.
71. Nebreda, A.R. & Porras, A. 2000. p38 MAP kinases: beyond the stress response. Trends Biochem Sci 25, 257-260.
72. Nicholls, D.G. & Locke, R.M. 1984. Thermogenic mechanism in brown fat. Physiol Rev 64, 1-64.
73. Nugent, C., Prins, J.B., Whitehead, J.P. et al. 2001. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation. Mol Endocrinol 15, 1729-1738.
74. Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O. & Ui, M. 1994. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J Biol Chem 269, 3568-3573.
75. Okuno, A., Tamemoto, H., Tobe, K. et al. 1998. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 101, 1354-1361.
76. Olefsky, J.M. 2000. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J Clin Invest 106, 467-472.
77. Olefsky, J.M. & Saltiel, A.R. 2000. PPAR gamma and the treatment of insulin resistance. Trends Endocrinol Metab 11, 362-368.
78. Peraldi, P., Hotamisligil, G.S., Buurman, W.A., White, M.F. & Spiegelman, B.M. 1996. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271, 13018-13022.
79. Pessin, J.E. & Saltiel, A.R. 2000. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106, 165-169.
80. Porras, A., Alvarez, A.M., Valladares, A. & Benito, M. 1998. p42/p44 mitogen-activated protein kinases activation is required for the insulin-like growth factor-I/insulin induced proliferation, but inhibits differentiation, in rat fetal brown adipocytes. Mol Endocrinol 12, 825-834.
81. Puigserver, P. & Spiegelman, B.M. 2003. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24, 78-90.
82. Rabelo, R., Camirand, A. & Silva, J.E. 1997. 3′, 5′-cyclic adenosine monophosphate-response sequences of the uncoupling protein gene are sequentially recruited during darglitazone-induced brown adipocyte differentiation. Endocrinology 138, 5325-5332.
83. Rieusset, J., Auwerx, J. & Vidal, H. 1999. Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes. Biochem Biophys Res Commun 265, 265-271.
84. Rondinone, C.M., Wang, L.M., Lonnroth, P., Wesslau, C., Pierce, J.H. & Smith, U. 1997. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 94, 4171-4175.
85. Rosen, E.D. & Spiegelman, B.M. 2001. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276, 37731-37734.
86. Rousset, S., Alves-Guerra, M.C., Mozo, J. et al. 2004. The biology of mitochondrial uncoupling proteins. Diabetes 53 (Suppl. 1), S130-S135.
87. Ruan, H., Miles, P.D., Ladd, C.M. et al. 2002. Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance. Diabetes 51, 3176-3188.
88. Rui, L., Aguirre, V., Kim, J.K. et al. 2001. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 107, 181-189.
89. Ryden, M., Dicker, A., Hauner, H.V. et al. 2002. Mapping of early signaling events in tumor necrosis factor-alpha-mediated lipolysis in human fat cells. J Biol Chem 277, 1085-1091.
90. Schmitz-Peiffer, C., Craig, D.L. & Biden, T.J. 1999. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274, 24202-24210.
91. Sivitz, W.I., DeSautel, S.L., Kayano, T., Bell, G.I. & Pessin, J.E. 1989. Regulation of glucose transporter messenger RNA in insulin-deficient states. Nature 340, 72-74.
92. Smith, U., Carvalho, E., Mosialou, E., Beguinot, F., Formisano, P. & Rondinone, C. 2000. PKB inhibition prevents the stimulatory effect of insulin on glucose transport and protein translocation but not the antilipolytic effect in rat adipocytes. Biochem Biophys Res Commun 268, 315-320.
93. Smith, U., Gogg, S., Johansson, A., Olausson, T., Rotter, V. & Svalstedt, B. 2001. Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes. FASEB J 15, 215-220.
94. Somwar, R., Sumitani, S., Taha, C., Sweeney, G. & Klip, A. 1998. Temporal activation of p70 S6 kinase and Aktl by insulin: PI 3-kinase-dependent and -independent mechanisms. Am J Physiol 275, E618-E625.
95. Souza, S.C., Yamamoto, M.T., Franciosa, M.D., Lien, P. & Greenberg, A.S. 1998. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. Diabetes 47, 691-695.
96. Sweeney, G., Somwar, R., Ramlal, T., Volchuk, A., Ueyama, A. & Klip, A. 1999. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 274, 10071-10078.
97. Sykiotis, G.P. & Papavassiliou, A.G. 2001. Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance. Mol Endocrinol 15, 1864-1869.
98. Teruel, T., Valverde, A.M., Alvarez, A., Benito, M. & Lorenzo, M. 1995. Differentiation of rat brown adipocytes during late foetal development: role of insulin-like growth factor I. Biochem J 310, 771-776.
99. Teruel, T., Valverde, A.M., Benito, M. & Lorenzo, M. 1996. Insulin-like growth factor I and insulin induce adipogenic-related gene expression in fetal brown adipocyte primary cultures. Biochem J 319, 627-632.
100. Teruel, T., Valverde, A.M., Navarro, P., Benito, M. & Lorenzo, M. 1998. Inhibition of PI 3-kinase and RAS blocks IGF-I and insulin-induced uncoupling protein 1 gene expression in brown adipocytes. J Cell Physiol 176, 99-109.
101. Teruel, T., Clapham, J.C. & Smith, S.A. 1999. PPARalpha activation by Wy 14643 induces transactivation of the rat UCP-1 promoter without increasing UCP-1 mRNA levels and attenuates PPARgamma-mediated increases in UCP-1 mRNA levels induced by rosiglitazone in fetal rat brown adipocytes. Biochem Biophys Res Commun 264, 311-315.
102. Teruel, T., Smith, S.A., Peterson, J. & Clapham, J.C. 2000. Synergistic activation of UCP-3 expression in cultured fetal rat brown adipocytes by PPARalpha and PPARgamma ligands. Biochem Biophys Res Commun 273, 560-564.
103. Teruel, T., Hernandez, R. & Lorenzo, M. 2001. Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes 50, 2563-2571.
104. Teruel, T., Hernandez, R., Benito, M. & Lorenzo, M. 2003. Rosiglitazone and retinoic acid induce uncoupling protein-1 (UCP-1) in a p38 mitogen-activated protein kinase-dependent manner in fetal primary brown adipocytes. J Biol Chem 278, 263-269.
105. Tortorella, L.L. & Pilch, P.F. 2002. C2C12 myocytes lack an insulin-responsive vesicular compartment despite dexamethasone-induced GLUT4 expression. Am J Physiol Endocrinol Metab 283, E514-E524.
106. Uysal, K.T., Wiesbrock, S.M., Marino, M.W. & Hotamisligil, G.S. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389, 610-614.
107. Uysal, K.T., Wiesbrock, S.M. & Hotamisligil, G.S. 1998. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity. Endocrinology 139, 4832-4838.
108. Valladares, A., Roncero, C., Benito, M. & Porras, A. 2001. TNF-alpha inhibits UCP-1 expression in brown adipocytes via ERKs. Opposite effect of p38MAPK. FEBS Lett 493, 6-11.
109. Valverde, A.M., Benito, M. & Lorenzo, M. 1992. Hormonal regulation of malic enzyme and glucose-6-phosphate-dehydrogenase expression in fetal brown-adipocyte primary cultures under non-proliferative conditions. Eur J Biochem 203, 313-319.
110. Valverde, A.M., Lorenzo, M., Teruel, T. & Benito, M. 1995. cAMP inhibits IGF-I-induced mitogenesis in fetal rat brown adipocytes: role of p21 ras. Exp Cell Res 218, 305-309.
111. Valverde, A.M., Lorenzo, M., Navarro, P. & Benito, M. 1997a. Phosphatidylinositol 3-kinase is a requirement for insulin-like growth factor I-induced differentiation, but not for mitogenesis, in fetal brown adipocytes. Mol Endocrinol 11, 595-607.
112. Valverde, A.M., Lorenzo, M., Teruel, T. & Benito, M. 1997b. Alterations in the insulin signaling pathway induced by immortalization and H-ras transformation of brown adipocytes. Endocrinology 138, 3195-3206.
113. Valverde, A.M., Lorenzo, M., Pons, S., White, M.F. & Benito, M. 1998a. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes. Mol Endocrinol 12, 688-697.
114. Valverde, A.M., Navarro, P., Benito, M. & Lorenzo, M. 1998b. H-ras induces glucose uptake in brown adipocytes in an insulin- and phosphatidylinositol 3-kinase-independent manner. Exp Cell Res 243, 274-281.
115. Valverde, A.M., Teruel, T., Navarro, P., Benito, M. & Lorenzo, M. 1998c. Tumor necrosis factor-alpha causes insulin receptor substrate-2-mediated insulin resistance and inhibits insulin-induced adipogenesis in fetal brown adipocytes. Endocrinology 139, 1229-1238.
116. Valverde, A.M., Kahn, C.R. & Benito, M. 1999a. Insulin signaling in insulin receptor substrate (IRS)-1-deficient brown adipocytes: requirement of IRS-1 for lipid synthesis. Diabetes 48, 2122-2131.
117. Valverde, A.M., Navarro, P., Teruel, T., Conejo, R., Benito, M. & Lorenzo, M. 1999b. Insulin and insulin-like growth factor I up-regulate GLUT4 gene expression in fetal brown adipocytes, in a phosphoinositide 3-kinase-dependent manner. Biochem J 337, 397-405.
118. Valverde, A.M., Lorenzo, M., Navarro, P., Mur, C. & Benito, M. 2000. Okadaic acid inhibits insulin-induced glucose transport in fetal brown adipocytes in an Akt-independent and protein kinase C zeta-dependent manner. FEBS Lett 472, 153-158.
119. Valverde, A.M., Mur, C., Pons, S. et al. 2001. Association of insulin receptor substrate 1 (IRS-1) y895 with Grb-2 mediates the insulin signaling involved in IRS-1-deficient brown adipocyte mitogenesis. Mol Cell Biol 21, 2269-2280.
120. Valverde, A.M., Arribas, M., Mur, C. et al. 2003. Insulin-induced up-regulated uncoupling protein-1 expression is mediated by insulin receptor substrate 1 through the phosphatidylinositol 3-kinase/Akt signaling pathway in fetal brown adipocytes. J Biol Chem 278, 10221-10231.
121. Virkamaki, A., Ueki, K. & Kahn, C.R. 1999. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103, 931-943.
122. Vlahos, C.J., Matter, W.F., Hui, K.Y. & Brown, R.F. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002). J Biol Chem 269, 5241-5248.
123. Wang, C.N., O'Brien, L. & Brindley, D.N. 1998. Effects of cell-permeable ceramides and tumor necrosis factor-alpha on insulin signaling and glucose uptake in 3T3-L1 adipocytes. Diabetes 47, 24-31.
124. Watson, R.T. & Pessin, J.E. 2001. Subcellular compartmentalization and trafficking of the insulin-responsive glucose transporter, GLUT4. Exp Cell Res 271, 75-83.
125. White, M.F. 2003. Insulin signaling in health and disease. Science 302, 1710-1711.
126. Withers, D.J. & White, M. 2000. Perspective: the insulin signaling system - a common link in the pathogenesis of type 2 diabetes. Endocrinology 141, 1917-1921.
127. Yuan, M., Konstantopoulos, N., Lee, J. et al. 2001. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293, 1673-1677.
128. Zisman, A., Peroni, O.D., Abel, E.D. et al. 2000. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6, 924-928.